Cutaneous Adverse Reactions of Anticancer Agents
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Dermatologic Clinics
- Vol. 37 (4) , 555-568
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Eccrine squamous syringometaplasia associated with vemurafenib therapyJournal of the American Academy of Dermatology, 2012
- Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their managementJournal of the European Academy of Dermatology and Venereology, 2012
- Treatment of chemotherapy-induced alopeciaDermatologic Therapy, 2011
- Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: Reappraisal of epidemiological, clinical, and pathological featuresJournal of the American Academy of Dermatology, 2011
- Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor–induced pruritusJournal of the American Academy of Dermatology, 2010
- Search for Evidence-Based Approaches for the Prevention and Palliation of Hand–Foot Skin Reaction (HFSR) Caused by the Multikinase Inhibitors (MKIs)The Oncologist, 2009
- Toxic erythema of chemotherapy: A useful clinical termJournal of the American Academy of Dermatology, 2008
- Chemotherapeutic agents and the skin: An updateJournal of the American Academy of Dermatology, 2008
- Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the footCancer, 2008
- Neutrophilic Hidradenitis Induced by Chemotherapy Involves Eccrine and Apocrine GlandsThe American Journal of Dermatopathology, 1997